AETHLON MEDICAL INC (AEMD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00808Y6041
AETHLON MEDICAL INC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -9.34 m USD | -7.29 m USD |
| EBIT | -13.38 m USD | -7.29 m USD |
| Net income | -13.39 m USD | -7.15 m USD |
| Diluted EPS – continuing operations | -8.58 USD | -10.61 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AETHLON MEDICAL INC
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
More stocks
- WILLAMETTE VALLEY VINEYARDS INC (WVVI)
- YUNHONG GREEN CTI LTD. (YHGJ)
- MDB Capital Holdings, LLC (MDBH)
- NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU)
- EQUATOR Beverage Co (MOJO)
- TerraVolt Holdings, Inc. (GEDC)
- Glucose Health, Inc. (GLUC)
- CISO Global, Inc. (CISO)
- AETERNUM HEALTH, INC. (AETN)
- ACCURAY INC (ARAY)
- INNOVATIVE DESIGNS INC (IVDN)
- GREENLITE VENTURES INC (GRNL)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.